CPC
CLVS

Congress Park Capital’s Clovis Oncology, Inc. CLVS Stock Holding History

Congress Park Capital’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
2019
Q1 		$313K Sell
2018
Q4 		$317K Buy
2018
Q3 		$504K Buy
2018
Q2 		$657K Buy
2018
Q1 		$244K Buy